Data Governance Planning PDA 12 May 2015
|
|
|
- Alexis Ferguson
- 10 years ago
- Views:
Transcription
1 Data Governance Planning PDA 12 May
2 Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions 2
3 Overview of Data Integrity 3
4 Data Information derived or obtained from raw data (e.g. a reported analytical result). Data can be electronic or paper based or Hybrid However all data must be: A attributable to the person generating the data L legible and permanent C contemporaneous O original record (or true copy ) A accurate Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March
5 Data Integrity Patient Safety Data Integrity is the extent to which all data are complete, consistent and accurate throughout the data lifecycle. Data integrity arrangements must ensure that the accuracy, completeness, content and meaning of data is retained throughout the data lifecycle. Product Quality Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March
6 Assurance of Data Integrity 6
7 How do we assure data integrity? Application of good documentation practices when using paper based, electronic or hybrid the same rules apply Any alteration made to the entry on a document should be signed and dated; the alteration should permit the reading of the original information. Where appropriate, the reason for the alteration should be recorded. 4.7 Handwritten entries should be made in a clear, legible, indelible way. 4.8 Records should be made or completed at the time each action is taken and in such a way that all significant activities concerning the manufacture of medicinal products are traceable. 7
8 How do we assure data integrity? Use and understanding data life cycle management Retrieval (legibility) Data creation Data retention Data processing Data reporting Data review 8
9 How do we assure data integrity? External environmental factors Control of external environmental factors requires consideration of: Increasingly complex supply chains Outsourcing of GxP operations Economic stressors Technological advances increased use of electronic systems 9
10 How do we assure data integrity? Internal environmental factors Control of internal environmental factors required consideration of: Quality Management Systems Adequate understanding and control of computerised systems and paper based recording system Senior stakeholder sponsorship of data integrity assurance activities 10
11 Data Governance 11
12 Data Governance The sum total of arrangements to ensure that data, irrespective of the format in which it is generated, is recorded, processed, retained and used to ensure a complete, consistent and accurate record throughout the data lifecycle Data governance should address data ownership throughout the lifecycle, and consider the design, operation and monitoring of processes / systems in order to comply with the principles of data integrity including control over intentional and unintentional changes to information. Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March
13 Data Governance The data governance system should be integral to the PQS The effort and resource assigned should be commensurate with the risk to product quality Should be balanced with other QA resource demands Note: Data is not homogeneous; therefore, neither is risk this should be considered when assigning resource The expectation is not to implement a forensic approach to data checking on a routine basis, but to design and operate a system which provides an acceptable state of control based risk At its best, data governance identifies risk both business and compliance risk by increasing oversight 13
14 Why Enterprises Struggle With Data Governance This has been attributed to: Cultural barriers Lack of senior-level sponsorship In the financial service industry, where data integrity has been a concern for many years, it has been reported in 2008 less than 10 percent of organizations will succeed at their first attempts at data governance. This statistic may prove very informative for our industry as we embark on addressing data integrity assurance within our organisations!! 14
15 Data Governance Application The core of data governance is creating a framework to ensure that data generated is: Recorded Processed Retained Used To ensure data, throughout the data lifecycle, is: complete consistent accurate 15
16 Food for thought Manufacturers and analytical laboratories should be aware that reverting from automated / computerised to manual / paperbased systems will not in itself remove the need for data integrity controls. This may also constitute a failure to comply with Article 23 of Directive 2001/83/EC, which requires an authorisation holder to take account of scientific and technical progress and enable the medicinal product to be manufactured and checked by means of generally accepted scientific methods. Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March
17 The Data Governance Plan 17
18 Elements to be considered An overarching data governance system, should include : Relevant policies, standards Effort and resource applied should be commensurate with criticality in terms of impact to product quality attributes Staff training - general & role specific e.g. audit team Technical controls (e.g. computer system access) Consideration should be given to the organisational controls (e.g. procedures) 18
19 Practical Elements to be considered Systems should be designed in a way that encourages compliance e.g. : Access to clocks for recording timed events Accessibility of batch records at locations where activities take place so that ad hoc data recording and later transcription to official records is not necessary Control over blank paper templates for data recording User access rights which prevent (or audit trail) data amendments Automated data capture or printers attached to equipment such as balances Proximity of printers to relevant activities Access to sampling points (e.g. for water systems) Access to raw data for staff performing data checking activities. 19
20 Data Governance Plan The Governance Plan should consider the following two elements: o Prevention better than cure!!! o Detection safe guarding the data!!! Prevention 1 QMS modernisation CSV Data review policy Standards Vendors (metrics/controls) QTAs and templates Detection 1 Auditing Identifying risk factors Data review process Whistleblower 1 Not exhaustive lists 20
21 Data Integrity Governance Plan Require a phased approach to role out o Consider a PDCA model 21
22 Data Integrity Governance Plan- Phase 1 o Define a governance structure Governance at senior level, roll out a grass roots Appoint a Data Integrity Compliance Officer not owner!!! o Gain buy in from SLT & senior stakeholders o Communications plan o Education up and down the organisation o Market the project to instil the appropriate culture and bring awareness o Develop Metrics for tracking (project and DI) o Develop a Tool Kit Glossary and definitions (common language) Policies Standards Procedures Whistle blowers charter and structures Templates Gap Assessments, URS, SLAs, Validation, QTA, Audit etc. 22
23 PQS updates to support Data Integrity governance Metrics expecting the Bow Wave. Driving the right behaviours Data integrity statement Quality Manual update Development and amendment of standards Development and amendment of policies Development and amendment of procedures Development and amendment of templates and forms Cultural and behavioural owned by all championed by quality Training 23
24 Data Integrity and the QRM process Data Integrity Governance Site Risk Register Site Control Strategy Senior Management Quality Data Integrity Compliance Office SME SME SME SME SME SME SME Gap Assessments Required effort commensurate with risk Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Data Integrity Risk Register & Control Strategy 24
25 Data Integrity Governance Plan- Phase 2 o Roll out the plan line in the sand o Mandated to each of the functional groups SMEs for actioning the activities o Complete a Gap Assessment of current state against the ideal Horizontal Cut Qualitative assessment Identify low, medium and high risk areas Deep Dive for the Medium, and High Risk areas commensurate with risk in the form of formal risk assessment Data lifecycle and business processing mapping 25
26 Data Integrity Governance Plan- Phase 2 Deviations Detailed data lifecycle and business processing mapping SOP Risk Assessment CAPA Identify High Medium Low risk Identification of risks for tracking role up residual risk into quality risk register for organisation Identify controls commensurate with risk 26
27 Data Integrity Governance Plan- Phase 3 & 4 Check Phase 3 o Governance team provide tracking and oversight during do phase tracking against project roll out o Important to understand that in the initial phase metrics may appear to look worse as issues are detected through the gap assessment and QRM activities Communication of this potential Bow Wave effect is important o Quick wins actions o Long term actions Act Phase 4 Sustain o Incorporate DI metrics into the Quality Management Review process and track o Incorporate DI into the self inspection & vendor qualification and oversight programs 27
28 Summary 28
29 Summary Overview of Data Integrity Applies to all data sources Patient Safety and Product Quality Assurance of Data Paper based, electronic or hybrid the same rules apply (ALCOA) Assuring appropriate data life cycle management Identifying and controlling internal and external factors Data Governance The core of data governance is creating a framework to ensure that data generated is recorded, processed, retained & used to ensure complete, consistent & accurate throughout the life cycle Cultural barriers and lack of senior-level sponsorship may be potential obstacles Reverting from automated / computerised to manual / paper-based systems will not in itself remove the need for data integrity controls The Data Governance Plan Should consider prevention and detection Relevant policies, standards, staff training, consideration should be given to the organisational controls, technical controls Effort and resource applied should be commensurate with criticality in terms of impact to product quality attributes Governance at a Management Level and roll out at a grass roots Things may appear worse before they get better metrics PQS, QRM and QMR 29
30 Questions? 30
31 Contact A Suite 2, Stafford House, Strand Road, Portmarnock, Co. Dublin, Ireland P +353 (0) E [email protected] F +353 (0) W 31
MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
MHRA Data Integrity Guidance and Expectations Document
MHRA Data Integrity Guidance and Expectations Document Nichola Stevens Alere International John Andrews Integrity Solutions April 23 rd 2015, Astellas, Chertsey 1 About this Session This is an interactive
ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064599 EudraLex The Rules Governing Medicinal Products
This interpretation of the revised Annex
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064587 EudraLex The Rules Governing Medicinal Products
Services Providers. Ivan Soto
SOP s for Managing Application Services Providers Ivan Soto Learning Objectives At the end of this session we will have covered: Types of Managed Services Outsourcing process Quality expectations for Managed
PHARMACEUTICAL QUALITY SYSTEM Q10
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step
Computerised Systems. Seeing the Wood from the Trees
Computerised Systems Seeing the Wood from the Trees Scope WHAT IS A COMPUTERISED SYSTEM? WHY DO WE NEED VALIDATED SYSTEMS? WHAT NEEDS VALIDATING? HOW DO WE PERFORM CSV? WHO DOES WHAT? IT S VALIDATED -
Manual 074 Electronic Records and Electronic Signatures 1. Purpose
1. Purpose The purpose of this document is to provide an interpretation of FDA 21 CFR Part 11, Electronic Records; Electronic Signatures (ER/ES) and to provide guidance for acceptable practices in the
Good Research Practice
Page 1 of 8 The Royal Veterinary College Introduction Preface Good Research Practice Funding bodies need to be assured of the quality and validity of research they fund and ensure their contractors are
Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,
Site visit inspection report on compliance with HTA minimum standards. London School of Hygiene & Tropical Medicine. HTA licensing number 12066
Site visit inspection report on compliance with HTA minimum standards London School of Hygiene & Tropical Medicine HTA licensing number 12066 Licensed under the Human Tissue Act 2004 for the storage of
From paper to electronic data
From paper to electronic data Bioindustrypark, October 10, 2013 Dr Alessandra Grande Ivrea GxP Test Facility QA Manager, Head Global BMT QA Research & Development Quality Assurance MerckSerono RBM Outline
OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD
OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD 1. The following draft Advisory Document will replace the 1995 OECD GLP Consensus Document number 10
GMP Training Course Quality Control. 20-21 October 2009. Lesley Graham Senior Inspector (UK)
GMP Training Course Quality Control 20-21 October 2009 Lesley Graham Senior Inspector (UK) Quality Control GMP in the QC Laboratory Certificates of Analysis Dealing with out of specification results Parametric
GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)
GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) Presented by: Patrick Costello Scientific Administrator, European Medicines Agency An agency of the European
How to implement a Quality Management System
How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485 within your
The Paperless QMS March 2012
The Paperless QMS March 2012 Overview Introductions What do we mean by Paperless QMS? Short history of the (pharma) Paperless QMS What do you need your Paperless QMS to do? Practical application and considerations
ICH guideline Q10 on pharmaceutical quality system
September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final
Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence
Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence Heather Longden Senior Marketing Manager, Informatics Regulatory Compliance 2015
New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)
Safeguarding public health New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Tony Orme, Senior GDP Inspector Inspection, Enforcement and Standards Division
GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme
GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes
Quality in pharmacovigilance systems
Quality in pharmacovigilance systems June 20 th, 2014 Lisa Stagi, Medical Compliance Leader Roche Spa Quality systems in pharmacovigilance: legal requirements Regulation 1235/2010 e Directive 2010/84 Legal
Guidance for Industry. Q10 Pharmaceutical Quality System
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
Reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples
28 February 2012 EMA/INS/GCP/532137/2010 GCP Inspectors Working Group Reflection paper for laboratories that perform the analysis or evaluation of clinical trial Draft agreed by GCP Inspectors Working
Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle
Quality Risk Management 11 November 2011 Galway, Ireland Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle Overview Regulatory
GCP Inspection of Ti Trial Master Files
Safeguarding public health GCP Inspection of Ti Trial Master Files DIA, 12th Conference on European Electronic Document Management/ EDM Crown copyright 2011 The materials featured within these MHRA presentation
GCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS
European Medicines Agency London, 17 October 2007 Doc. Ref. EMEA/505620/2007 GCP INSPECTORS WORKING GROUP REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS
Recent Updates on European Requirements and what QPs are expected to do
Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status
How To Inspect A Blood Bank
Site visit inspection report on compliance with HTA minimum standards Belfast Cord Blood Bank HTA licensing number 11077 Licensed for the procurement, processing, testing, storage, distribution and import/export
OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT
OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (14) 19 6R MANAGEMENT OF DOCUMENTS AND RECORDS Full document title and reference Management of Documents and Records PA/PH/OMCL
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT PA/PH/OMCL (08) 69 3R Full document title and reference Document type VALIDATION OF COMPUTERISED SYSTEMS Legislative basis - CORE DOCUMENT
ICH Q10 Pharmaceutical Quality System (PQS)
ICH Q10 Pharmaceutical Quality System (PQS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Q10 PQS Guideline Background Objectives
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.
Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation
Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality
What is necessary to provide good clinical data for a clinical trial?
What is necessary to provide good clinical data for a clinical trial? Alain Barrois, Assistant Clinical Trials Operations Manager #EBMT2015 www.ebmt.org Is this a (typical) clinical trial? 2 Agenda Introduction
Pharmaceutical Quality Systems: US Perspective
Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical
QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT
QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT Heather Longden Senior Marketing Manager Waters Corporation Boston Chapter Educational Meeting June 2016 About Waters Lab Informatics Separations
Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1
Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.
Job description Job title Directorate Pay band Responsible to Base/location Process Engineer Production SEO Process Engineering Manager Porton Hours/sessions per week 37.5 Job type Permanent INTRODUCTION
Managing & Validating Research Data
Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical
Harmonizing Change Control Processes Globally
Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses
The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials
Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials Vanessa Grant and Tim Stiles VERSION 2 Published by
TRIAL MASTER FILE- SPONSORED
gsop-06-04 - Management of TMF for ENHT/ WHHT Sponsored CTIMPs Page 1 of 16 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust TRIAL MASTER
GAMP 4 to GAMP 5 Summary
GAMP 4 to GAMP 5 Summary Introduction This document provides summary information on the GAMP 5 Guide and provides a mapping to the previous version, GAMP 4. It specifically provides: 1. Summary of Need
PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)
January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal
Guideline on good pharmacovigilance practices (GVP)
1 2 20 February 2012 EMA/541760/2011 3 4 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration
United Kingdom Science Park Association Good Practice Guide Electronic Quality Management System for SMEs
United Kingdom Science Park Association Good Practice Guide Electronic Quality Management System for SMEs METRICS AUDITS EQUIPMENT CAPA TRAINING CONFORMANCE NON- DOCUMENTS CHANGE CONTROL PROCEDURES COMPLAINTS
Clinical database/ecrf validation: effective processes and procedures
TITOLO SLIDE Testo Slide Testo Slide Testo Slide Clinical database/ecrf validation: effective processes and procedures IV BIAS ANNUAL CONGRESS Padova September, 26 th 2012 PQE WORKSHOP: What's new in Computerized
Auditing as a Component of a Pharmaceutical Quality System
Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a
Seminario SSFA. New Guideline on Good Pharmacovigilance Practice (GVP) Fare clic per modificare lo stile del sottotitolo dello schema
Seminario SSFA New Guideline on Good Pharmacovigilance Practice (GVP) Pharmacovigilance Systems and their Quality Systems Milano, 20th April 2012 GIULIA M. VALSECCHI The proposed GVP - Module 1 Guidance
ICH Q10 - Pharmaceutical Quality System
WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,
Guidance for Industry: Quality Risk Management
Guidance for Industry: Quality Risk Management Version 1.0 Drug Office Department of Health Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. What is risk?... 4 5. Integrating
IT Governance. What is it and how to audit it. 21 April 2009
What is it and how to audit it 21 April 2009 Agenda Can you define What are the key objectives of How should be structured Roles and responsibilities Key challenges and barriers Auditing Scope Test procedures
Adoption by GCP Inspectors Working Group for consultation 14 June 2011. End of consultation (deadline for comments) 15 February 2012
10 December 2013 EMA/INS/GCP/600788/2011 Compliance and Inspection Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials, with particular
Application Of Quality Metrics In Determining Overall State Of Quality. & The Health Of Associated PQS FDA s Current Thinking
Course Objectives: How does industry use Metrics? FDA Challenges and equirements and Use of Quality Metrics Complexities of Implementation (Industry Feedback) What does it all mean? Key in isk identification
QUALITY MANAGEMENT SYSTEM (QMS) ASSESSMENT CHECKLIST
1. QUALITY MANAGEMENT SYSTEM QUALITY MANAGEMENT SYSTEM (QMS) ASSESSMENT CHECKLIST 1.1 Quality Management System General 1.1.1 Is objective evidence available to demonstrate that the MDSAP site has defined,
QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 002-3 25 September 2007 RECOMMENDATION ON QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES PIC/S September
Site visit inspection report on compliance with HTA minimum standards. Belfast Cord Blood Bank. HTA licensing number 11077.
Site visit inspection report on compliance with HTA minimum standards Belfast Cord Blood Bank HTA licensing number 11077 Licensed for the procurement, processing, testing, storage, distribution and import/export
This SOP may also be used by staff from other NHS areas, or organisations, with prior agreement.
Standard Operating Procedure: SOP Number: SOP-QA-32 Version No: 1 Author: Date: (Gary Cooper, Named Sponsor Archivist, NHS Grampian and University of Aberdeen) 1-9-15 Approved by: Date: 1-9-15 (Professor
Example of a food company quality
Appendix A manual Example of a food company quality Contents Date: 13/03/95 RME-QLMN-OO Page 1 of 3 Section Title ISO 9001 reference 01 In trod uction 02 Purpose 03 Scope 04 Definitions 05 Management responsibility
OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING NUMBER 10 GLP CONSENSUS DOCUMENT
GENERAL DISTRIBUTION OCDE/GD(95)115 OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING NUMBER 10 GLP CONSENSUS DOCUMENT THE APPLICATION OF THE PRINCIPLES OF GLP TO COMPUTERISED
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical
A Guide to Archiving of Electronic Records
A Guide to Archiving of Electronic Records 18th February 2014 A Guide to Archiving of Electronic Records The Scientific Archivists Group (SAG) formed a Working Party to develop guidance to assist in the
Pharmacovigilance System Master File (PSMF), QPPV and audits
Federal Agency for Medicines and Health Products (FAMHP) Pharmacovigilance System Master File (PSMF), QPPV and audits Matthijs Nele, PhV Inspector, DG Inspection BRAS - FAMHP/NM/ 1 Content Introduction
QUALITY MANAGEMENT SYSTEM REQUIREMENTS General Requirements. Documentation Requirements. General. Quality Manual. Control of Documents
Chapter j 38 Self Assessment 729 QUALITY MANAGEMENT SYSTEM REQUIREMENTS General Requirements 1. Establishing and implementing a documented quality management system 2. Implementing a documented quality
COMMISSION DIRECTIVE 2003/94/EC
L 262/22 COMMISSION DIRECTIVE 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal
Document Control Procedure
ABN 5810 5001 465 ADMIN 3.3 Document Control Procedure Version 4 K.B. Taylor CEO RISSB 27 August 2012 ADMIN 3.3 Document Control Procedure Version 4 August 2012 DOCUMENT CONTROL Identification Document
FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997)
www.qadata.co.za Introduction FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997) INITIAL REGULATION RELEASED High profile audit findings Industry complaints to wasting
21 CFR Part 11 Electronic Records & Signatures
Gap Analysis - Checklist 21 CFR Part 11 Electronic Records & Signatures his document is a proposal and starting point only. he type and extent of documentation depends on the process environment. he proposed
ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE
ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Global Pharma Sourcing Conference December 6-7, 2011 Philadelphia, USA Nigel J. Smart, Ph.D. Smart Consulting
Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry
EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry Version March 2015 QUESTIONS
Establish Collaborative Strategies to Better Manage a Global Vendor Network Devise a Proper Float Plan
Establish Collaborative Strategies to Better Manage a Global Vendor Network Devise a Proper Float Plan CBI s Biopharmaceutical Forum on Clinical and Commercial Global Supply Chain Excellence Sandy Onorato
Solvency II Data audit report guidance. March 2012
Solvency II Data audit report guidance March 2012 Contents Page Introduction Purpose of the Data Audit Report 3 Report Format and Submission 3 Ownership and Independence 4 Scope and Content Scope of the
Drinking Water Quality Management Plan Review and Audit Guideline
Drinking Water Quality Management Plan Review and Audit Guideline This publication has been compiled by Queensland Water Supply Regulator, Department of Energy and Water Supply. State of Queensland, 2013.
ISO/IEC 17025 QUALITY MANUAL
1800 NW 169 th Pl, Beaverton, OR 97006 Revision F Date: 9/18/06 PAGE 1 OF 18 TABLE OF CONTENTS Quality Manual Section Applicable ISO/IEC 17025:2005 clause(s) Page Quality Policy 4.2.2 3 Introduction 4
Implementing an ISO 9001 Quality Management System
Implementing an ISO 9001 Quality Management System ETI Group This guide to implementing an ISO 9001 Quality Management System (QMS) was prepared by ETI Group. The guide is based on our experiences assisting
Best Practice In A Change Management System
Quality & Compliance Associates, LLC Best Practice In A Change Management System President Quality & Compliance Associates, LLC Change Control and Its Role in a Continuous Improvement Environment 3 Benefits
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products- authorisations, European Medicines Agency Brussels, EudraLex The Rules Governing Medicinal
Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants
Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Alex D. Kanarek, PhD BioProcess Technology Consultants, Inc. Strategic Institute Quality
Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.
Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management
How To Manage An Electronic Standard Operating Procedure
AGIT Management of electronic SOPs 1 / 14 GOOD LABORATORY PRACTICE (GLP) GUIDELINES FOR THE MANAGEMENT OF ELECTRONIC STANDARD OPERATING PROCEDURES (SOPs) IN A GLP ENVIRONMENT Working Group Information
State Meat and Poultry Inspection (MPI) Program Laboratory Quality Management System Checklist
This checklist is intended to help laboratories improve the quality of their testing programs with regard to meat and poultry testing samples, in order to ensure those laboratories are at least equal to
Guidance for electronic trial data capturing of clinical trials
Guidance for electronic trial data capturing of clinical trials 1 st November, 2007 Japan Pharmaceutical Manufacturing Association pg. 1 Table of Contents 1. Background... 3 2. Purpose... 3 3. Scope...
White paper: How to implement Good Documentation Practices
White paper: How to implement Good Documentation Practices This white paper describes the fundamental requirements of Good Documentation Practice (GDP) routinely used within the pharmaceutical industry
Enterprise Level Change Control: A Life Science Business Imperative. Presented by: Carl Ning Solutions Delivery Manager Sparta Systems
Enterprise Level Change Control: A Life Science Business Imperative Presented by: Carl Ning Solutions Delivery Manager Sparta Systems Agenda Global Change Control: An Overview Benefits and Challenges Change
Code of Corporate Governance
www.surreycc.gov.uk Making Surrey a better place Code of Corporate Governance October 2013 1 This page is intentionally blank 2 CONTENTS PAGE Commitment to good governance 4 Good governance principles
"Data Manufacturing: A Test Data Management Solution"
W14 Concurrent Session 5/4/2011 3:00 PM "Data Manufacturing: A Test Data Management Solution" Presented by: Fariba Alim-Marvasti Aetna Healthcare Brought to you by: 340 Corporate Way, Suite 300, Orange
Testing Automated Manufacturing Processes
Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls
Operations. Group Standard. Business Operations process forms the core of all our business activities
Standard Operations Business Operations process forms the core of all our business activities SMS-GS-O1 Operations December 2014 v1.1 Serco Public Document Details Document Details erence SMS GS-O1: Operations
Guideline on good pharmacovigilance practices (GVP)
22 June 2012 EMA/541760/2011 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration with Member
INSURANCE ACT 2008 CORPORATE GOVERNANCE CODE OF PRACTICE FOR REGULATED INSURANCE ENTITIES
SD 0880/10 INSURANCE ACT 2008 CORPORATE GOVERNANCE CODE OF PRACTICE FOR REGULATED INSURANCE ENTITIES Laid before Tynwald 16 November 2010 Coming into operation 1 October 2010 The Supervisor, after consulting
Clinical Trial Logistics
Company Brochure Clinical Trial Logistics contents 1. 2. 3. 4. 5. 6. About us Values Facility Quality Management System Services Why PCS Clinical Trial Logistics about us MEET US PHARMA COMPLEX SOLUTIONS
